The Infectious Disease Institute, Ltd. (IDI) in Kampala, Uganda, was founded in 2004. The institute is part of the Mulago Hospital Complex which is located close to the centre of Kampala. It is affiliated with the College of Health Science of Makerere University and receives support from both government and private resources, including the Gates Foundation, GILEAD, Pfizer and Tibotec. There are currently 20 members of staff and volunteers working at the institute. The clinic is one of the largest ART centres in Uganda and treats patients with HIV and related infectious diseases. As of the 1st of April 2010, there were approximately 9000 HIV positive patients on follow-up in this clinic, of whom approximately 5500 patients are currently on first-line treatment, and approximately 500 patients have been started on second-line therapy. The site has a great deal of experience in clinical research and has participated in numerous trials including DART, the ARKS Study, the PIP Study, the TMC 125 Trial, the TAMS Study and the Tropism Study. The key EARNEST site personnel are Dr. Andrew Kambugu (PI), Dr. Philippa Easterbrook (Co-PI) and Ruth Nalumenya (Trial Manager) and these are ably supported by a comprehensive and enthusiastic team.
More information on IDI can be obtained via http://idi.mak.ac.ug/.